Navigating chemical space for biology and medicine (Q28298611)

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Europe PubMed Central

title

Navigating chemical space for biology and medicine (English)

0 references

author

Christopher A. Lipinski

object named as

Christopher Lipinski

series ordinal

1

0 references

author name string

Andrew Hopkins

series ordinal

2

0 references

language of work or name

English

0 references

publication date

16 December 2004

0 references

published in

Nature

0 references

volume

432

0 references

issue

7019

0 references

page(s)

855-61

0 references

cites work

1 reference

Hit and lead generation: beyond high-throughput screening

21 April 2017

1 reference

Modern biomedical research: an internally self-consistent universe with little contact with medical reality?

21 April 2017

1 reference

Click Chemistry: Diverse Chemical Function from a Few Good Reactions

21 April 2017

1 reference

Site-directed ligand discovery

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

21 April 2017

1 reference

Small-molecule inhibitors of protein-protein interactions: progressing towards the dream

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

Discovering high-affinity ligands for proteins: SAR by NMR

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

Chemical genetics resulting from a passion for synthetic organic chemistry

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

NIH Molecular Libraries Initiative

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Comprehensive Survey of Combinatorial Library Synthesis: 2002

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Selective optimization of side activities: another way for drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Knockouts model the 100 best-selling drugs--will they model the next 100?

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Chemical genetics: exploring and controlling cellular processes with chemical probes

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Kinase inhibitors: not just for kinases anymore

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Comparison of Assay Technologies for a Nuclear Receptor Assay Screen Reveals Differences in the Sets of Identified Functional Antagonists

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Prediction of biological activity for high-throughput screening using binary kernel discrimination.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Nonleadlikeness and leadlikeness in biochemical screening

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Biochemical mechanisms of drug action: what does it take for success?

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Drug-like annotation and duplicate analysis of a 23-supplier chemical database totalling 2.7 million compounds

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Functional group contributions to drug-receptor interactions.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Molecular complexity and its impact on the probability of finding leads for drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

From magic bullets to designed multiple ligands

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

The Nobel chronicles. 1988: James Whyte Black, (b 1924), Gertrude Elion (1918-99), and George H Hitchings (1905-98).

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Implications of protein flexibility for drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Antibody libraries in drug and target discovery.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Designing proteins that work using recombinant technologies

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Novel chemical genetic approaches to the discovery of signal transduction inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Unlocking the potential of the human genome with RNA interference

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Intracellular antibodies as specific reagents for functional ablation: future therapeutic molecules

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Fragment-based lead discovery

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

SAR by MS: a ligand based technique for drug lead discovery against structured RNA targets

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Discovering novel ligands for macromolecules using X-ray crystallographic screening

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

SAR and X-ray. A new approach combining fragment-based screening and rational drug design: application to the discovery of nanomolar inhibitors of Src SH2.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

High-throughput crystallography for lead discovery in drug design.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

The growing impact of click chemistry on drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Tethering: fragment-based drug discovery

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Chemography: the art of navigating in chemical space.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Chemical space navigation in lead discovery

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Characteristic physical properties and structural fragments of marketed oral drugs.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Can we learn to distinguish between "drug-like" and "nondrug-like" molecules?

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Toward designing drug-like libraries: a novel computational approach for prediction of drug feasibility of compounds

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Recognizing molecules with drug-like properties

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Drug-like properties and the causes of poor solubility and poor permeability

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Simple selection criteria for drug-like chemical matter

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Molecular properties that influence the oral bioavailability of drug candidates

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Drugs, leads, and drug-likeness: an analysis of some recently launched drugs

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Prediction of 'drug-likeness'.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Selection criteria for drug-like compounds

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Allosteric inhibition through core disruption

1 reference

https://api.crossref.org/works/10.1038%2FNATURE03193

7 January 2021

Identifiers

DOI

10.1038/NATURE03193

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

ADS bibcode

2004Natur.432..855L

0 references

1025290270

0 references

Fatcat ID

release_4x7ohql36jaa3em35x6kzh7nwa

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4x7ohql36jaa3em35x6kzh7nwa

24 November 2022

mapped directly with Wikidata item

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

15602551

1 reference

Consolidated OpenCitations Corpus – April 2017